ADMA Biologics markets three FDA-approved immune globulin products, with ASCENIV serving as its main growth driver. Read why ADMA stock is upgraded to strong buy.

New research confirms it: the creativity of artificial intelligence (AI) is a myth. Although current generative AI models may appear to be autonomous creative agents, analyzing their imaginative ...

KB Home is maintained at a hold as weak demand and macro headwinds drive sharply reduced FY2026 guidance. Click here to find ...

Mistral AI launches Voxtral TTS, an open-weight enterprise voice model that runs on a smartphone and challenges ElevenLabs in ...

Unregulated AI use in academia creates ethical risks, including plagiarism and compromised originality, while human effort ...

Deep learning has been successfully applied in the field of medical diagnosis, and improving the accurate classification of ...

Research is identifying alternative methods to the polygraph, but some doubt whether true lie detection is possible.

Against the backdrop of global energy transition, smart grids have become pivotal yet face challenges in resilience, security, stability, and market ...

While the cuts hit all demographics, younger biomedical researchers may have suffered the most from the Trump ...

Many college students have to take out loans to cover tuition costs. College graduates with a computer science major ...

"A Turkish Company at the Champions League of Education" At the ASU+GSV Summit — attended by more than 7,000 global ...